US Stocks
/
MetaVia Inc. Share Price
MetaVia Inc. Share Price

MetaVia Inc. Share Price

NASDAQ: MTVA | Micro Cap
$1.33
-$0.17 (-11.33%) Last updated on 09 Oct, 2026 | 00:53 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MetaVia Inc. Stock Performance

Open
$1.44
Prev. Close
$1.50
Circuit Range
N/A
Day Range
$1.33 - $1.44
Year Range
$0.57 - $12.68
Volume
1,140
Average Traded
$1.37

MetaVia Inc. Share Price Today

As of 9 October 2026, MetaVia Inc.'s share price is $1.33. The stock opened at $1.44, compared to its previous close of $1.50. During today's trading session, MetaVia Inc.'s share price traded between $1.33 and $1.44, with an average price of $1.39. Over the past 52 weeks, the stock has recorded a high of $12.68 and a low of $0.57. In terms of performance, MetaVia Inc.'s share price has declined by 8.59% over the last six months and is up 35.71% on a year-on-year basis.

MetaVia Inc. Share Price Chart

$1.33$1.44
L
Show Current Price
H

MetaVia Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.35M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-211.76%
Profit Margin
N/A
Debt to Equity
0.42
Quarterly Earnings Growth YoY
-57.40%

MetaVia Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.38-$1.93-$3.82-$5.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A42.90%-97.93%-39.27%

MetaVia Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$27.59-$12.97
Net Profit MarginN/AN/A
Income ChangeN/A52.99%

About MetaVia Inc.

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.

MetaVia Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.54
$1.34
-14.65%
Sep 2026
$1.68
$1.57
-7.10%
Aug 2026
$1.51
$1.69
+19.01%
Jul 2026
$1.43
$1.42
-0.35%
Jun 2026
$2.76
$1.43
-49.38%
May 2026
$1.46
$2.81
+93.47%
Apr 2026
$1.23
$1.46
+21.25%
Mar 2026
$1.53
$1.20
-20.53%
Feb 2026
$2.53
$1.51
-37.86%
Jan 2026
$8.55
$2.43
-71.45%
Dec 2025
$0.77
$8.51
+970.44%
Nov 2025
$1.07
$0.80
-18.88%

MTVA Share Price FAQs

What is MetaVia Inc. share price today?

chevron-up
MetaVia Inc. share price today is $1.33 as on October 9, 2026 at 12:53 am IST.

What is the 52 week high and 52 week low of MetaVia Inc. stock?

chevron-up
The 52 week high of MetaVia Inc. stock is $12.68, while the 52 week low is $0.57 as of 9 Oct '26.

What is MTVA's market capitalisation today?

chevron-up
MTVA market capitalisation is $2.35M as of October 9, 2026, at 4:45 pm IST.

What is MTVA's net income for the last quarter?

chevron-up
MTVA's net income for the last quarter is -5.32B USD.

What is the 5 year returns of MTVA?

chevron-up
The 5 year returns of MTVA is -99.69% as on 9 Oct '26.

What is the high & low stock price of MTVA today?

chevron-up
MTVA stock price hit a high of $1.44 and low of $1.33 as of 9 Oct '26.

Can I buy MTVA shares in India?

chevron-up
Yes. You can buy MTVA in India by opening an international trading account.